{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T04:10:46Z","timestamp":1769573446211,"version":"3.49.0"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T00:00:00Z","timestamp":1600819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K07455"],"award-info":[{"award-number":["20K07455"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17K15628"],"award-info":[{"award-number":["17K15628"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["15K08975"],"award-info":[{"award-number":["15K08975"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.550366","type":"journal-article","created":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T13:53:57Z","timestamp":1600869237000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Galectin-3 as a Therapeutic Target for NSAID-Induced Intestinal Ulcers"],"prefix":"10.3389","volume":"11","author":[{"given":"Ah-Mee","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sundar","family":"Khadka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumitaka","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiichi","family":"Omura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsugu","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel K.","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-Tong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikuo","family":"Tsunoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,9,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1016\/0016-5085(93)90667-2","article-title":"Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans.","volume":"104","author":"Bjarnason","year":"1993","journal-title":"Gastroenterology."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1111\/j.1572-0241.2002.06037.x","article-title":"Hospitalization and mortality rates from peptic ulcer disease and GI bleeding in the 1990s: relationship to sales of nonsteroidal anti-inflammatory drugs and acid suppression medications.","volume":"97","author":"Lewis","year":"2002","journal-title":"Am J Gastroenterol."},{"key":"B3","first-page":"137","article-title":"Detection and prevention of NSAID-induced enteropathy.","volume":"3","author":"Davies","year":"2000","journal-title":"J Pharm Pharm Sci."},{"key":"B4","doi-asserted-by":"crossref","first-page":"20807","DOI":"10.1016\/S0021-9258(17)31891-4","article-title":"Galectins. Structure and function of a large family of animal lectins.","volume":"269","author":"Barondes","year":"1994","journal-title":"J Biol Chem."},{"key":"B5","doi-asserted-by":"publisher","first-page":"247","DOI":"10.14670\/HH-26.247","article-title":"Regulated expression of galectin-3, a multifunctional glycan-binding protein, in haematopoietic and non-haematopoietic tissues.","volume":"26","author":"Sundblad","year":"2011","journal-title":"Histol Histopathol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/S0002-9440(10)64975-9","article-title":"Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses.","volume":"156","author":"Hsu","year":"2000","journal-title":"Am J Pathol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1046\/j.1462-5822.2002.00183.x","article-title":"Association of a macrophage galactoside-binding protein with Mycobacterium-containing phagosomes.","volume":"4","author":"Beatty","year":"2002","journal-title":"Cell Microbiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1172\/JCI17592","article-title":"Critical role of galectin-3 in phagocytosis by macrophages.","volume":"112","author":"Sano","year":"2003","journal-title":"J Clin Invest."},{"key":"B9","doi-asserted-by":"publisher","first-page":"395","DOI":"10.2353\/ajpath.2008.070870","article-title":"Galectin-3 reduces the severity of pneumococcal pneumonia by augmenting neutrophil function.","volume":"172","author":"Farnworth","year":"2008","journal-title":"Am J Pathol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.4049\/jimmunol.168.4.1813","article-title":"Role of galectin-3 as an adhesion molecule for neutrophil extravasation during streptococcal pneumonia.","volume":"168","author":"Sato","year":"2002","journal-title":"J Immunol."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026004","article-title":"LPS-induced galectin-3 oligomerization results in enhancement of neutrophil activation.","volume":"6","author":"Fermino","year":"2011","journal-title":"PLoS One."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1128\/IAI.01299-15","article-title":"Galectin-3 plays an important role in innate immunity to gastric infection by Helicobacter pylori.","volume":"84","author":"Park","year":"2016","journal-title":"Infect Immun."},{"key":"B13","doi-asserted-by":"publisher","first-page":"4718","DOI":"10.4049\/jimmunol.177.7.4718","article-title":"Galectin-3 induces death of Candida species expressing specific beta-1,2-linked mannans.","volume":"177","author":"Kohatsu","year":"2006","journal-title":"J Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1164\/rccm.201106-0965OC","article-title":"Regulation of transforming growth factor-\u03b21-driven lung fibrosis by galectin-3.","volume":"185","author":"Mackinnon","year":"2012","journal-title":"Am J Respir Crit Care Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1124\/jpet.114.218370","article-title":"Functions of galectin-3 and its role in fibrotic diseases.","volume":"351","author":"Li","year":"2014","journal-title":"J Pharmacol Exp Ther."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1111\/apt.13816","article-title":"Randomised clinical study: GR-MD-02, a galectin-3 inhibitor, vs. placebo in patients having non-alcoholic steatohepatitis with advanced fibrosis.","volume":"44","author":"Harrison","year":"2016","journal-title":"Aliment Pharmacol Ther."},{"key":"B17","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1159\/000353574","article-title":"The role of galectin-3 as a marker of cancer and inflammation in a stage IV ovarian cancer patient with underlying pro-inflammatory comorbidities.","volume":"6","author":"Eliaz","year":"2013","journal-title":"Case Rep Oncol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3892\/ijmm.2017.3311","article-title":"Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review).","volume":"41","author":"Dong","year":"2018","journal-title":"Int J Mol Med."},{"key":"B19","first-page":"165","article-title":"Role of COX inhibition in pathogenesis of NSAID-induced small intestinal damage.","author":"Takeuchi","year":"2003","journal-title":"J Physiol Pharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1159\/000374106","article-title":"NSAID-induced small intestinal damage-roles of various pathogenic factors.","volume":"91","author":"Takeuchi","year":"2015","journal-title":"Digestion."},{"key":"B21","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1242\/jcs.020800","article-title":"Loss of galectin-3 impairs membrane polarisation of mouse enterocytes in vivo.","volume":"121","author":"Delacour","year":"2008","journal-title":"J Cell Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000138047","article-title":"Indometacin-induced gastrointestinal lesions in relation to tissue concentration, food intake and bacterial invasion in the rat.","volume":"30","author":"Weissenborn","year":"1985","journal-title":"Pharmacology."},{"key":"B23","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3892\/ijmm.2011.602","article-title":"Role of tumor necrosis factor-\u03b1 in the pathogenesis of indomethacin-induced small intestinal injury in mice.","volume":"27","author":"Fukumoto","year":"2011","journal-title":"Int J Mol Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/j.1574-6941.2008.00520.x","article-title":"Distribution of beta-glucosidase and beta-glucuronidase activity and of beta-glucuronidase gene gus in human colonic bacteria.","volume":"66","author":"Dabek","year":"2008","journal-title":"FEMS Microbiol Ecol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3109\/00498254.2013.811314","article-title":"Bacterial \u03b2-glucuronidase inhibition protects mice against enteropathy induced by indomethacin, ketoprofen or diclofenac: mode of action and pharmacokinetics.","volume":"44","author":"Saitta","year":"2014","journal-title":"Xenobiotica."},{"key":"B26","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/gut.2007.125963","article-title":"Non-steroidal anti-inflammatory drug-induced small intestinal damage is Toll-like receptor 4 dependent.","volume":"57","author":"Watanabe","year":"2008","journal-title":"Gut."},{"key":"B27","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1365-2036.2010.04324.x","article-title":"Clinical trial: the effects of a probiotic mixture on non-steroidal anti-inflammatory drug enteropathy \u2013 a randomized, double-blind, cross-over, placebo-controlled study.","volume":"32","author":"Montalto","year":"2010","journal-title":"Aliment Pharmacol Ther."},{"key":"B28","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1006\/phrs.1999.0550","article-title":"Roles of enterobacteria, nitric oxide and neutrophil in pathogenesis of indomethacin-induced small intestinal lesions in rats.","volume":"40","author":"Konaka","year":"1999","journal-title":"Pharmacol Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"23.1.1","DOI":"10.1002\/cpim.25","article-title":"Gut microbiome standardization in control and experimental mice.","volume":"117","author":"McCoy","year":"2017","journal-title":"Curr Protoc Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1017\/s0022172400026851","article-title":"The dose at which neomycin and polymyxin B can be applied for selective decontamination of the digestive tract in mice.","volume":"84","author":"Emmelot","year":"1980","journal-title":"J Hyg (Lond)."},{"key":"B31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1099\/00207713-24-1-35","article-title":"Bacteroides multiacidus, a new species from the feces of humans and pigs.","volume":"24","author":"Mitsuoka","year":"1974","journal-title":"Int J Syst Bacteriol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/sj.jim.2900627","article-title":"Inhibiting sulfate-reducing bacteria in biofilms by expressing the antimicrobial peptides indolicidin and bactenecin.","volume":"22","author":"Jayaraman","year":"1999","journal-title":"J Ind Microbiol Biotechnol."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/nu9121329","article-title":"Meta-analysis of fecal microbiota and metabolites in experimental colitic mice during the inflammatory and healing phases.","volume":"9","author":"Osaka","year":"2017","journal-title":"Nutrients."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9141","article-title":"Sialic acid catabolism drives intestinal inflammation and microbial dysbiosis in mice.","volume":"6","author":"Huang","year":"2015","journal-title":"Nat Commun."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.01385","article-title":"Alleviation of intestinal inflammation by oral supplementation with 2-fucosyllactose in mice.","volume":"10","author":"Grabinger","year":"2019","journal-title":"Front Microbiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.chom.2011.04.009","article-title":"Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease.","volume":"9","author":"Bloom","year":"2011","journal-title":"Cell Host Microbe."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1053\/j.gastro.2017.11.003","article-title":"Enteric delivery of regenerating family member 3 alpha alters the intestinal microbiota and controls inflammation in mice with colitis.","volume":"154","author":"Darnaud","year":"2018","journal-title":"Gastroenterology."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0118972","article-title":"Endogenous prostaglandins and afferent sensory nerves in gastroprotective effect of hydrogen sulfide against stress-induced gastric lesions.","volume":"10","author":"Magierowski","year":"2015","journal-title":"PLoS One."},{"key":"B39","doi-asserted-by":"publisher","first-page":"E6297","DOI":"10.1073\/pnas.1704847114","article-title":"Identification of a vesicular ATP release inhibitor for the treatment of neuropathic and inflammatory pain.","volume":"114","author":"Kato","year":"2017","journal-title":"Proc Natl Acad Sci USA."},{"key":"B40","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1093\/glycob\/cwj035","article-title":"Exploring the role of galectin 3 in kidney function: a genetic approach.","volume":"16","author":"Bichara","year":"2006","journal-title":"Glycobiology."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19020392","article-title":"Dissecting the structure-activity relationship of galectin-ligand interactions.","volume":"19","author":"Chan","year":"2018","journal-title":"Int J Mol Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human.","volume":"7","author":"Nair","year":"2016","journal-title":"J Basic Clin Pharm."},{"key":"B43","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2144\/btn-2018-0017","article-title":"Forensic luminol reaction for detecting fecal occult blood in experimental mice.","volume":"65","author":"Park","year":"2018","journal-title":"BioTechniques."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.550366\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T17:59:30Z","timestamp":1617472770000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.550366\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,23]]},"references-count":43,"alternative-id":["10.3389\/fimmu.2020.550366"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.550366","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,23]]},"article-number":"550366"}}